WallStreetZenWallStreetZen

NASDAQ: CRON
Cronos Group Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their CRON stock forecasts and price targets.

Forecast return on equity

Is CRON forecast to generate an efficient return?

Company
N/A
Industry
281.78%
Market
145.67%

Forecast return on assets

Is CRON forecast to generate an efficient return on assets?

Company
N/A
Industry
153.39%

CRON earnings per share forecast

What is CRON's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.02-110.93%
Avg 2 year Forecast
$0.07-49%
Avg 3 year Forecast
$0.11-19.86%
CRON's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

CRON revenue forecast

What is CRON's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$140.8M+12.97%
Avg 2 year Forecast
$183.8M+47.49%
Avg 3 year Forecast
$154.7M+24.2%
CRON's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CRON earnings growth forecast

How is CRON forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
-4.52%
Industry
208.23%
Market
40.98%
CRON's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
CRON's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
CRON's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

CRON revenue growth forecast

How is CRON forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
10.89%
Industry
123.12%
Market
25.33%
CRON's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CRON's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CRON vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
CRON$2.49N/AN/A
PCRX$21.36$30.00+40.45%Buy
COLL$35.41$42.33+19.55%Buy
AMPH$24.18$31.60+30.69%Buy
AQST$6.72$9.25+37.65%Buy
View Top Pharmaceutical Stocks

Cronos Group Stock Forecast FAQ

What is CRON's earnings growth forecast for 2025-2027?

(NASDAQ: CRON) Cronos Group's forecast annual earnings growth rate of -4.52% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 208.23%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 40.98%.

Cronos Group's earnings in 2025 is $49,443,000.On average, 4 Wall Street analysts forecast CRON's earnings for 2025 to be -$5,896,911, with the lowest CRON earnings forecast at -$30,216,851, and the highest CRON earnings forecast at $20,234,499. On average, 4 Wall Street analysts forecast CRON's earnings for 2026 to be $27,518,918, with the lowest CRON earnings forecast at $22,662,638, and the highest CRON earnings forecast at $32,375,198.

In 2027, CRON is forecast to generate $43,244,014 in earnings, with the lowest earnings forecast at $41,548,170 and the highest earnings forecast at $44,515,897.

If you're new to stock investing, here's how to buy Cronos Group stock.

What is CRON's revenue growth forecast for 2025-2027?

(NASDAQ: CRON) Cronos Group's forecast annual revenue growth rate of 10.89% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 123.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.33%.

Cronos Group's revenue in 2025 is $124,589,000.On average, 4 Wall Street analysts forecast CRON's revenue for 2025 to be $54,247,727,206, with the lowest CRON revenue forecast at $48,451,025,130, and the highest CRON revenue forecast at $59,774,635,967. On average, 4 Wall Street analysts forecast CRON's revenue for 2026 to be $70,824,599,299, with the lowest CRON revenue forecast at $52,767,718,165, and the highest CRON revenue forecast at $89,274,607,834.

In 2027, CRON is forecast to generate $59,639,739,310 in revenue, with the lowest revenue forecast at $57,300,245,852 and the highest revenue forecast at $61,393,395,855.

What is CRON's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: CRON) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 153.39%.

What is CRON's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: CRON) Cronos Group's current Earnings Per Share (EPS) is $0.14. On average, analysts forecast that CRON's EPS will be -$0.02 for 2025, with the lowest EPS forecast at -$0.08, and the highest EPS forecast at $0.05. On average, analysts forecast that CRON's EPS will be $0.07 for 2026, with the lowest EPS forecast at $0.06, and the highest EPS forecast at $0.08. In 2027, CRON's EPS is forecast to hit $0.11 (min: $0.11, max: $0.12).

What is CRON's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: CRON) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.